RetractedArticleCancer gene therapy2022

Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting.

Yichu Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.